comparemela.com

Latest Breaking News On - Hiddo heerspink - Page 1 : comparemela.com

Novartis: presented results for kidney disease

Novartis has presented the results of a pre-specified interim analysis of the Phase III ALIGN study of atrasentan, an investigational oral selective endothelin A receptor antagonist, in patients with.

David soergelHiddo heerspinkMetabolic developmentEuropean renal associationGroningen university medical centerProfessor hiddo heerspinkGlobal headNovartis cardiovascular

ALIGN Study: Atrasentan Shows Significant Benefit on Proteinuria in IgAN at 36 Weeks

Atrasentan significantly reduces proteinuria in patients with IgA nephropathy, showing a 36.1% reduction compared to placebo at 36 weeks.

Bonnie schneiderHiddo heerspinkIgan foundationGeorge institute for global health hiddo heerspinkDepartment of clinical pharmacyEuropean renal association congressUniversity medical center groningenGeorge instituteGlobal healthClinical trialsPersonalized medicineClinical pharmacyUniversity medical center

Diabetes Drug Enhances Heart, Kidney Health Outcomes

Diabetes Drug Enhances Heart, Kidney Health Outcomes
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Hiddo heerspinkRenal trialist consortiumSenior researchGeorge institute for global healthAmerican collegeCardiology annual scientific sessionBrendon neuenSenior research fellowGeorge instituteGlobal healthAnalysis cardio renal trialist consortiumProf hiddo heerspinkGlucose co transporterMajor adverse cardiovascular outcomes

ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease

But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention

United statesNeeraj dhaunGavin brian chapmanHiddo heerspinkAmerican society of nephrologyUniversity medical center groningenUniversity of edinburghAmerican society

Zibotentan/Dapagliflozin Mix Cuts Albuminuria in ZENITH-CKD Trial

Zibotentan/Dapagliflozin Mix Cuts Albuminuria in ZENITH-CKD Trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSharon barrHiddo heerspinkAmerican society of nephrologyUniversity medical center groningenDepartment of clinical pharmacyUniversity of groningenAmerican societyKidney weekClinical pharmacyExecutive vice presidentRare disease

vimarsana © 2020. All Rights Reserved.